Literature DB >> 10469349

Chronic allograft nephropathy: An update.

L C Paul1.   

Abstract

Chronic allograft nephropathy is the most prevalent cause of renal transplant failure in the first post-transplant decade, but its pathogenesis has remained elusive. Clinically, it is characterized by a slow but variable loss of function, often in combination with proteinuria and hypertension. The histopathology is also not specific, but transplant glomerulopathy and multilayering of the peritubular capillaries are highly characteristic. Several risk factors have been identified, such as advanced donor age, delayed graft function, repeated acute rejection episodes, vascular rejection episodes, and rejections that occur late after transplantation. A common feature of chronic allograft nephropathy is that it develops in grafts that have undergone previous damage, although the mechanism(s) responsible for the progressive fibrosis and tissue remodeling has not yet been defined. Hypotheses to explain chronic allograft nephropathy include the immunolymphatic theory, the cytokine excess theory, the loss of supporting architecture theory, and the premature senescence theory. The most effective option to prevent chronic allograft nephropathy is to avoid graft injury from both immune and nonimmune mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469349     DOI: 10.1046/j.1523-1755.1999.00611.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  38 in total

1.  HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Robin P F Dullaart; Jan-Stephan F Sanders; Stephan J L Bakker; Uwe J F Tietge
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.

Authors:  Luis F Quintana; Josep M Campistol; Maria P Alcolea; Elisenda Bañon-Maneus; Amandaé Sol-González; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

Review 3.  Mass spectrometry in chronic kidney disease research.

Authors:  Michael L Merchant
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

4.  Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Philip M Murphy
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice.

Authors:  Ding Ai; Chiyuan Chen; Seongah Han; Anjali Ganda; Andrew J Murphy; Rebecca Haeusler; Edward Thorp; Domenico Accili; Jay D Horton; Alan R Tall
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

6.  Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction.

Authors:  Negar Azarpira; M Bagheri; Gh A Raisjalali; M H Aghdaie; S Behzadi; H Salahi; M Rahsaz; M Darai; M J Ashraf; B Geramizadeh
Journal:  Mol Biol Rep       Date:  2008-05-03       Impact factor: 2.316

Review 7.  Doppler ultrasound in kidney diseases: a key parameter in clinical long-term follow-up.

Authors:  Leonardo Spatola; Simeone Andrulli
Journal:  J Ultrasound       Date:  2016-04-16

8.  Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.

Authors:  Takako Tabata; Hisaaki Kawakatsu; Ekaterina Maidji; Takao Sakai; Keiko Sakai; June Fang-Hoover; Motohiko Aiba; Dean Sheppard; Lenore Pereira
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

9.  Urine proteomics to detect biomarkers for chronic allograft dysfunction.

Authors:  Luís F Quintana; Amanda Solé-Gonzalez; Susana G Kalko; Elisenda Bañon-Maneus; Manel Solé; Fritz Diekmann; Alex Gutierrez-Dalmau; Joaquin Abian; Josep M Campistol
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

10.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.